Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Nakamura

Showing results (521-530 of 709) with videos related to

Pageof 71
Sort By:
Oncotarget|July 3, 2018
Risk factors of ineffective drainage in uncovered self-expandable metal stenting for unresectable malignant hilar biliary stricturesKoji Takahashi, Toshio Tsuyuguchi, Atsushi Saiga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]Hiroshi Wada, Hiroaki Nagano, Keizo Dono, et al.
JACC. Cardiovascular Interventions|June 6, 2024
A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan TrialOsamu Iida, Yoshimitsu Soga, Shigeru Saito, et al.
Oncology Letters|September 12, 2012
Reduced CD73 expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastasesMasahiro Matsuyama, Masatoshi Wakui, Makoto Monnai, et al.
Hepato-Gastroenterology|April 11, 2007
Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branchHiroaki Nagano, Masato Sakon, Hidetoshi Eguchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 23, 2017
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]Hitoshi Kato, Hiroaki Nagano, Hideo Ota, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 21, 2020
Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening IschemiaMakoto Utsunomiya, Mitsuyoshi Takahara, Osamu Iida, et al.
Journal of Cardiology|May 3, 2021
Hospital performance in a large urban acute myocardial infarction emergency care system: Tokyo Cardiovascular Care Unit networkTakeshi Yamamoto, Toshiaki Otsuka, Nobuko Yoshida, et al.
Anticancer Research|April 30, 2022
Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab RegimenHiroaki Tanioka, Ken Shimada, Akihito Tsuji, et al.
Pageof 71

Showing results (521-530 of 709) with videos related to

Sort By:
Pageof 71
Oncotarget|July 3, 2018
Risk factors of ineffective drainage in uncovered self-expandable metal stenting for unresectable malignant hilar biliary stricturesKoji Takahashi, Toshio Tsuyuguchi, Atsushi Saiga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]Hiroshi Wada, Hiroaki Nagano, Keizo Dono, et al.
JACC. Cardiovascular Interventions|June 6, 2024
A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan TrialOsamu Iida, Yoshimitsu Soga, Shigeru Saito, et al.
Oncology Letters|September 12, 2012
Reduced CD73 expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastasesMasahiro Matsuyama, Masatoshi Wakui, Makoto Monnai, et al.
Hepato-Gastroenterology|April 11, 2007
Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branchHiroaki Nagano, Masato Sakon, Hidetoshi Eguchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 23, 2017
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]Hitoshi Kato, Hiroaki Nagano, Hideo Ota, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 21, 2020
Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening IschemiaMakoto Utsunomiya, Mitsuyoshi Takahara, Osamu Iida, et al.
Journal of Cardiology|May 3, 2021
Hospital performance in a large urban acute myocardial infarction emergency care system: Tokyo Cardiovascular Care Unit networkTakeshi Yamamoto, Toshiaki Otsuka, Nobuko Yoshida, et al.
Anticancer Research|April 30, 2022
Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab RegimenHiroaki Tanioka, Ken Shimada, Akihito Tsuji, et al.
Pageof 71